Search

Your search keyword '"Herbelin L"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Herbelin L" Remove constraint Author: "Herbelin L"
98 results on '"Herbelin L"'

Search Results

1. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

2. Consistent improvement with eculizumab across muscle groups in myasthenia gravis

3. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

4. Eculizumab Improves Fatigue in Refractory Generalized Myasthenia Gravis

5. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy

6. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

8. RASCH ANALYSIS OF THE IBMFRS: 7

14. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (Quality of Life Research, (2019), 28, 8, (2247-2254), 10.1007/s11136-019-02148-2)

16. O.33Subcutaneous immunoglobulin in myasthenia gravis: results of a North American open label study

17. P.02Phase 2/3 study of Arimoclomol in sporadic inclusion body myositis: study design

18. Randomized Trial of Thymectomy in Myasthenia Gravis

19. LB0002 Safety and Tolerability of Arimoclomol in Patients with Sporadic Inclusion Body Myositis: A Randomised, Double-Blind, Placebo-Controlled, Phase IIa Proof-of-Concept Trial

21. Clinical and Molecular Characterization of Non-Dystrophic Myotonia (P05.181)

23. O04 Efficacy of mexiletine in non-dystrophic myotonia: results of an international multi-centred randomised controlled trial

30. The natural history of amyotrophic lateral sclerosis

31. Pilot trial of etanercept in the treatment of inclusion-body myositis

32. 542P INSPIRE-IBM: an NIH-funded, two-year, multicenter, observational study in inclusion body myositis (IBM)-an update.

33. 541P Comparative evaluation of pulmonary function tests and self-reported respiratory function in inclusion body myositis based on NT5c1A antibody serology status.

34. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

35. Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study.

36. Measurement properties of the Inclusion Body Myositis Functional Rating Scale.

37. Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN.

38. Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.

39. Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study.

40. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial.

41. Open-label pilot study of ranolazine for cramps in amyotrophic lateral sclerosis.

42. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.

43. A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine.

44. Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial.

45. Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysis.

46. Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.

47. Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis.

48. Measuring Clinical Treatment Response in Myasthenia Gravis.

49. An instrumented timed up and go in facioscapulohumeral muscular dystrophy.

50. Less is More in Diabetic Neuropathy Diagnosis: Comparison of Quantitative Sudomotor Axon Reflex and Skin Biopsy.

Catalog

Books, media, physical & digital resources